Latham & Watkins

Marc Granger

Deals
4
Latest
Aug 2026

Firm

Deals by year
Marc Granger: deals by year0123420252026 YTD: 4 M&A42026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Marc Granger was named on, most recent first
Aug 2026 global rights for MT-7117 (dersimelagon) Tanabe PharmaLEO PharmaAsset saleLegal adviser to LEO Pharma (acquirer)Completed435.0Pharma+2LEO Pharma acquisition of global rights for MT-7117 (dersimelagon)
May 2026 Replay –LEO PharmaAcquisitionLegal adviser to LEO Pharma (acquirer)Announced50.0Biotech+2LEO Pharma acquisition of Replay
Apr 2026 HLSG Intermediate ––AcquisitionLegal adviser to Sterling (acquirer)Announced–Healthcare Services+1Acquisition of HLSG Intermediate
Feb 2026 Molycop American Industrial PartnersApollo Global ManagementAcquisitionLegal adviser to Apollo Global Management, Inc. and Tega Industries (acquirer)Announced1,450.0Mining Services+1Apollo Global Management acquisition of Molycop

Deals where Marc Granger is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.